guigulch, If this continues with nothing until Tuesday morning or longer I take this as positive.
And why is that? Of course I would expect you and others on the board to continue your magical thinking. But it really would be interesting to learn the LOGIC behind your statement.
For me, the fact we didn't hear anything TODAY, one day after most of the company's financing ran out and the company was as quiet as a tomb, would be scary. Remember this: Bill McGann announced the company was pursuing strategic alternatives on Dec. 3 of last year. Seven months ago. He announced investment bankers and attorneys who would be hired to assist in looking at alternatives. Given the money Implant has had to pay them -- and presumably continues to pay them -- they're doing a heck of a job, putting in countless hours in behalf of their client. Still, no alternatives in sight. Is there?
Implant Sciences is a small, fairly uncomplicated company in terms of its products and markets. Even more telling, there is clearly a very limited range of companies who would need ETD technology to flesh out their line. In other words, the review should have been expeditious, one would think. That the company is still in limbo should not make anyone feel good, or optimistic, or I can't wait for Tuesday because things get better every day...
News 
Market Data 
Discover 
